U.S. FDA revokes emergency use status of drug touted by Trump for COVID-19
Published
The U.S. Food and Drug Administration on Monday revoked the emergency use authorization for malaria drug hydroxychloroquine as a treatment for COVID-19, the use of which has been championed by U.S. President Donald Trump.
Full Article